Jay Anders, MD, CMO of Medicomp Systems writes for Medical Economics on AHIP’s recent press release and their stance on the new CMS final rule regarding Risk Adjustment Data Validation for Medicare Advantage (MA) plans. Read the full article here.
Jay Anders, MD, CMO of Medicomp Systems writes for Medical Economics on AHIP’s recent press release and their stance on the new CMS final rule regarding Risk Adjustment Data Validation for Medicare Advantage (MA) plans. Read the full article here.